vs
英美资源集团（AMSC）与VERACYTE, INC.（VCYT）财务数据对比。点击上方公司名可切换其他公司
VERACYTE, INC.的季度营收约是英美资源集团的1.9倍（$140.6M vs $74.5M），英美资源集团净利率更高（158.1% vs 29.3%，领先128.8%），英美资源集团同比增速更快（21.4% vs 18.5%），VERACYTE, INC.自由现金流更多（$48.8M vs $2.4M），过去两年英美资源集团的营收复合增速更高（33.2% vs 20.5%）
英美资源集团是一家总部位于英国伦敦的跨国矿业企业，是全球最大的铂金生产商，产量约占全球总产出的40%，同时也是钻石、铜、镍、铁矿石、多卤石、炼焦煤的主要供应商，业务布局覆盖非洲、亚洲、大洋洲、欧洲、南北美洲多个地区。
Veracyte是一家领先的分子诊断企业，专注开发专有的基因组检测方案，可实现癌症及其他复杂疾病的早期精准检测，产品服务于医疗机构以优化临床决策，核心市场位于美国，正稳步拓展全球业务布局。
AMSC vs VCYT — 直观对比
营收规模更大
VCYT
是对方的1.9倍
$74.5M
营收增速更快
AMSC
高出2.8%
18.5%
净利率更高
AMSC
高出128.8%
29.3%
自由现金流更多
VCYT
多$46.4M
$2.4M
两年增速更快
AMSC
近两年复合增速
20.5%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $74.5M | $140.6M |
| 净利润 | $117.8M | $41.1M |
| 毛利率 | 30.7% | 72.5% |
| 营业利润率 | 4.5% | 26.4% |
| 净利率 | 158.1% | 29.3% |
| 营收同比 | 21.4% | 18.5% |
| 净利润同比 | 4679.1% | 704.8% |
| 每股收益（稀释后） | $2.62 | $0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMSCVCYT
| Q4 25 | $74.5M | $140.6M | ||
| Q3 25 | $65.9M | $131.9M | ||
| Q2 25 | $72.4M | $130.2M | ||
| Q1 25 | $66.7M | $114.5M | ||
| Q4 24 | $61.4M | $118.6M | ||
| Q3 24 | $54.5M | $115.9M | ||
| Q2 24 | $40.3M | $114.4M | ||
| Q1 24 | $42.0M | $96.8M |
净利润AMSCVCYT
| Q4 25 | $117.8M | $41.1M | ||
| Q3 25 | $4.8M | $19.1M | ||
| Q2 25 | $6.7M | $-980.0K | ||
| Q1 25 | $1.2M | $7.0M | ||
| Q4 24 | $2.5M | $5.1M | ||
| Q3 24 | $4.9M | $15.2M | ||
| Q2 24 | $-2.5M | $5.7M | ||
| Q1 24 | $-1.6M | $-1.9M |
毛利率AMSCVCYT
| Q4 25 | 30.7% | 72.5% | ||
| Q3 25 | 31.0% | 69.2% | ||
| Q2 25 | 33.8% | 69.0% | ||
| Q1 25 | 26.5% | 69.5% | ||
| Q4 24 | 26.6% | 66.4% | ||
| Q3 24 | 28.7% | 68.2% | ||
| Q2 24 | 30.3% | 68.1% | ||
| Q1 24 | 24.8% | 64.5% |
营业利润率AMSCVCYT
| Q4 25 | 4.5% | 26.4% | ||
| Q3 25 | 4.5% | 17.4% | ||
| Q2 25 | 7.8% | -4.0% | ||
| Q1 25 | 2.5% | 2.5% | ||
| Q4 24 | 2.1% | 3.5% | ||
| Q3 24 | -1.4% | 10.4% | ||
| Q2 24 | -8.2% | 4.0% | ||
| Q1 24 | -5.3% | -4.8% |
净利率AMSCVCYT
| Q4 25 | 158.1% | 29.3% | ||
| Q3 25 | 7.2% | 14.5% | ||
| Q2 25 | 9.3% | -0.8% | ||
| Q1 25 | 1.8% | 6.2% | ||
| Q4 24 | 4.0% | 4.3% | ||
| Q3 24 | 9.0% | 13.1% | ||
| Q2 24 | -6.3% | 5.0% | ||
| Q1 24 | -3.8% | -1.9% |
每股收益（稀释后）AMSCVCYT
| Q4 25 | $2.62 | $0.50 | ||
| Q3 25 | $0.11 | $0.24 | ||
| Q2 25 | $0.17 | $-0.01 | ||
| Q1 25 | $0.04 | $0.09 | ||
| Q4 24 | $0.06 | $0.07 | ||
| Q3 24 | $0.13 | $0.19 | ||
| Q2 24 | $-0.07 | $0.07 | ||
| Q1 24 | $-0.03 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $141.1M | $362.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $536.8M | $1.3B |
| 总资产 | $719.5M | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMSCVCYT
| Q4 25 | $141.1M | $362.6M | ||
| Q3 25 | $212.9M | $315.6M | ||
| Q2 25 | $207.9M | $219.5M | ||
| Q1 25 | $79.5M | $186.1M | ||
| Q4 24 | $75.2M | $239.1M | ||
| Q3 24 | $72.1M | $274.1M | ||
| Q2 24 | $93.5M | $235.9M | ||
| Q1 24 | $90.5M | $209.2M |
股东权益AMSCVCYT
| Q4 25 | $536.8M | $1.3B | ||
| Q3 25 | $342.2M | $1.3B | ||
| Q2 25 | $333.1M | $1.2B | ||
| Q1 25 | $197.1M | $1.2B | ||
| Q4 24 | $192.7M | $1.2B | ||
| Q3 24 | $187.0M | $1.2B | ||
| Q2 24 | $143.3M | $1.1B | ||
| Q1 24 | $144.6M | $1.1B |
总资产AMSCVCYT
| Q4 25 | $719.5M | $1.4B | ||
| Q3 25 | $445.6M | $1.4B | ||
| Q2 25 | $452.8M | $1.3B | ||
| Q1 25 | $310.5M | $1.3B | ||
| Q4 24 | $310.3M | $1.3B | ||
| Q3 24 | $298.4M | $1.3B | ||
| Q2 24 | $240.1M | $1.2B | ||
| Q1 24 | $232.8M | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.2M | $52.6M |
| 自由现金流经营现金流 - 资本支出 | $2.4M | $48.8M |
| 自由现金流率自由现金流/营收 | 3.2% | 34.7% |
| 资本支出强度资本支出/营收 | 1.2% | 2.7% |
| 现金转化率经营现金流/净利润 | 0.03× | 1.28× |
| 过去12个月自由现金流最近4个季度 | $16.0M | $126.6M |
8季度趋势，按日历期对齐
经营现金流AMSCVCYT
| Q4 25 | $3.2M | $52.6M | ||
| Q3 25 | $6.5M | $44.8M | ||
| Q2 25 | $4.1M | $33.6M | ||
| Q1 25 | $6.3M | $5.4M | ||
| Q4 24 | $5.9M | $24.5M | ||
| Q3 24 | $12.7M | $30.0M | ||
| Q2 24 | $3.4M | $29.6M | ||
| Q1 24 | $2.2M | $-9.0M |
自由现金流AMSCVCYT
| Q4 25 | $2.4M | $48.8M | ||
| Q3 25 | $5.1M | $42.0M | ||
| Q2 25 | $3.3M | $32.3M | ||
| Q1 25 | $5.3M | $3.5M | ||
| Q4 24 | $5.3M | $20.4M | ||
| Q3 24 | $12.1M | $27.7M | ||
| Q2 24 | $3.1M | $26.8M | ||
| Q1 24 | $1.9M | $-11.1M |
自由现金流率AMSCVCYT
| Q4 25 | 3.2% | 34.7% | ||
| Q3 25 | 7.7% | 31.8% | ||
| Q2 25 | 4.6% | 24.8% | ||
| Q1 25 | 7.9% | 3.1% | ||
| Q4 24 | 8.7% | 17.2% | ||
| Q3 24 | 22.3% | 23.9% | ||
| Q2 24 | 7.8% | 23.4% | ||
| Q1 24 | 4.6% | -11.5% |
资本支出强度AMSCVCYT
| Q4 25 | 1.2% | 2.7% | ||
| Q3 25 | 2.1% | 2.1% | ||
| Q2 25 | 1.1% | 1.0% | ||
| Q1 25 | 1.6% | 1.6% | ||
| Q4 24 | 0.9% | 3.5% | ||
| Q3 24 | 1.1% | 1.9% | ||
| Q2 24 | 0.7% | 2.4% | ||
| Q1 24 | 0.7% | 2.2% |
现金转化率AMSCVCYT
| Q4 25 | 0.03× | 1.28× | ||
| Q3 25 | 1.37× | 2.34× | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 5.22× | 0.76× | ||
| Q4 24 | 2.38× | 4.80× | ||
| Q3 24 | 2.60× | 1.98× | ||
| Q2 24 | — | 5.16× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMSC
| Equipment And Systems | $56.0M | 75% |
| Megatran | $14.1M | 19% |
| Comtrafo Industria De Transformadores Eletricos SA | $4.6M | 6% |
VCYT
| Testing | $135.8M | 97% |
| Products | $3.8M | 3% |
| Biopharmaceutical And Other | $686.0K | 0% |
